JVMRX
Price
$27.95
Change
-$0.00 (-0.00%)
Updated
Apr 18, 6:59 PM EST
JVMSX
Price
$27.80
Change
-$0.00 (-0.00%)
Updated
Apr 18, 6:59 PM EST
Ad is loading...

JVMRX vs JVMSX ᐉ Comparison: Which is Better to Invest?

Header iconJVMRX vs JVMSX Comparison
Open Charts JVMRX vs JVMSXBanner chart's image
JHancock Disciplined Value Mid Cap R6
Price$27.95
Change-$0.00 (-0.00%)
VolumeN/A
CapitalizationN/A
JHancock Disciplined Value Mid Cap R2
Price$27.80
Change-$0.00 (-0.00%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
JVMRX vs JVMSX Comparison Chart

Loading...

VS
JVMRX vs. JVMSX commentary
Apr 20, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JVMRX is a Hold and JVMSX is a Hold.

FUNDAMENTALS
Fundamentals
JVMRX (21.8B) and JVMSX (21.8B) have equal amount of cash in the bank . JVMRX pays higher dividends than JVMSX: JVMRX (0.93) vs JVMSX (0.52). JVMRX was incepted earlier than JVMSX: JVMRX (13 years) vs JVMSX (12 years). JVMRX (41.00) and JVMSX (41.00) have comparable annual turnover. JVMSX has a lower initial minimum investment than JVMRX: JVMSX (0) vs JVMRX (1000000). JVMRX (12.95) and JVMSX (12.38) have marching annual gain over last year. JVMRX return over 5 years is better than : 41.02 vs. JVMSX (38.06).
JVMRXJVMSXJVMRX / JVMSX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence13 years12 years-
Gain YTD2.1562.018107%
Front LoadN/AN/A-
Min. Initial Investment10000000-
Min. Initial Investment IRAN/AN/A-
Net Assets21.8B21.8B100%
Annual Yield % from dividends0.930.52179%
Returns for 1 year12.9512.38105%
Returns for 3 years4.863.28148%
Returns for 5 years41.0238.06108%
Returns for 10 years59.5153.79111%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CMCM3.370.28
+9.06%
Cheetah Mobile
TPB27.000.41
+1.54%
Turning Point Brands
CNSP0.20N/A
-0.20%
CNS Pharmaceuticals
DSGX90.13-0.41
-0.45%
Descartes Systems Group
RXST51.75-1.08
-2.04%
RxSight